Phase Ib evaluation of a self-adjuvanted protamine formulated mRNA-based active cancer immunotherapy, BI1361849 (CV9202), combined with local radiation treatment in patients with stage IV non-small cell lung cancer - Concepedia

Concepedia

Publication | Open Access

Phase Ib evaluation of a self-adjuvanted protamine formulated mRNA-based active cancer immunotherapy, BI1361849 (CV9202), combined with local radiation treatment in patients with stage IV non-small cell lung cancer

DOI Full Paper Access

213

Citations

34

References

2019

Year

Alexandros Papachristofilou, M. Hipp, Ute Klinkhardt, Martin Früh, Martin Sebastian, Miklos Pless, Richard Cathomas, Wolfgang Hilbe, Georg Pall, Thomas Wehler,

Journal for ImmunoTherapy of Cancer

Abstract

ClinicalTrials.gov identifier: NCT01915524 .

References

	Year	Citations
New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1) E. Eisenhauer, P. Therasse, Jan Bogaerts, European Journal of Cancer Surgical OncologyRecist GuidelineMedicineCancer ManagementSolid Tumours	2008	28.6K
Comprehensive genomic characterization of squamous cell lung cancers Nature EngineeringSomatic VariantTumor HeterogeneityMedicinePathology	2012	3.9K
An immunogenic personal neoantigen vaccine for patients with melanoma Patrick A. Ott, Zhuting Hu, Derin B. Keskin, Nature VaccinationTumor ImmunologyMelanomaImmunologyTherapeutic Vaccine	2017	2.8K
Personalized RNA mutanome vaccines mobilize poly-specific therapeutic immunity against cancer Uğur Şahin, Evelyna Derhovanessian, Matthias Miller, Nature VaccinationAllergyMedicineImmunologyTumor Immunity	2017	2.4K
Immunologic Correlates of the Abscopal Effect in a Patient with Melanoma Michael A. Postow, Margaret K. Callahan, Christopher A. Barker, New England Journal of Medicine ImmunologyPathologyDermatologyImmune SystemImmunotherapy	2012	2K
Lineage relationship and protective immunity of memory CD8 T cell subsets E. John Wherry, Volker Teichgräber, Todd C. Becker, Nature Immunology Protective ImmunityAutoimmune DiseaseAdaptive Immune SystemT-regulatory CellImmunology	2003	1.8K
Fractionated but Not Single-Dose Radiotherapy Induces an Immune-Mediated Abscopal Effect when Combined with Anti–CTLA-4 Antibody Md. Zahidunnabi Dewan, Ashley E. Galloway, Noriko Kawashima, Clinical Cancer Research	2009	1.6K
Blockade of CTLA-4 on both effector and regulatory T cell compartments contributes to the antitumor activity of anti–CTLA-4 antibodies Karl S. Peggs, Sergio A. Quezada, Cynthia A. Chambers, The Journal of Experimental Medicine	2009	937
An Abscopal Response to Radiation and Ipilimumab in a Patient with Metastatic Non–Small Cell Lung Cancer Encouse B. Golden, Sandra Demaria, Peter B. Schiff, Cancer Immunology Research ImmunologyImmunoeditingPathologyImmunotherapyTumor Markers	2013	686
Maximizing Tumor Immunity With Fractionated Radiation Dörthe Schaue, Josephine A. Ratikan, Keisuke S. Iwamoto, International Journal of Radiation OncologyBiologyPhysics Radiation TherapyMedicineTumor ImmunityOncologyRadiation Oncology	2011	557

Page 1